Blindness: Clinical Trials

3 trials for Blindness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3
Phase 31Unknown 1

Follow Blindness: new trials by email Literature Review of Blindness trials Research Report on Blindness

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
Tirzepatide - Wolfram Syndrome
Phase 2UnknownOspedale San Raffaele102024-01-012024-02-22
Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome
Depakine - Wolfram Syndrome
Phase 2UnknownCentre d'Etude des Cellules Souches232021-11-262023-11-28
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
sepofarsen - Leber Congenital Amaurosis 10, Blindness
Phase 2 / Phase 3UnknownProQR Therapeutics152021-03-232022-03-25

Narrower conditions

Wolfram Syndrome (2)  ·  Diabetes Mellitus (1)  ·  Eye Abnormalities (1)  ·  Eye Diseases (1)  ·  Leber Congenital Amaurosis (1)  ·  Leber Congenital Amaurosis 10 (1)  ·  Meckel Syndrome, Type 4 (1)  ·  Neurologic Manifestations (1)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)  ·  Retinal Dystrophies (1)  ·  Sensation Disorders (1)  ·  Vision Disorders (1)

Broader conditions

Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Eye Diseases, Hereditary (3)  ·  Nervous System Diseases (3)  ·  Abnormalities, Multiple (2)  ·  Cranial Nerve Diseases (2)  ·  Deaf-Blind Disorders (2)  ·  Deafness (2)  ·  Diabetes Insipidus (2)  ·  Diabetes Mellitus, Type 1 (2)  ·  Ear Diseases (2)  ·  Endocrine System Diseases (2)  ·  Eye Diseases (2)  ·  Female Urogenital Diseases (2)

Interventions

Tirzepatide (1)  ·  Valproic Acid (1)

Sponsors

Centre d'Etude des Cellules Souches (1)  ·  Ospedale San Raffaele (1)  ·  ProQR Therapeutics (1)

Countries

Italy (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Lorenzo Piemonti, MD (1)